• Nasdaq hearings panel granted TNL Mediagene continued listing on Nasdaq Capital Market, subject to meeting bid-price compliance by Sept. 21, 2026.
• Stockholders’ equity compliance must be restored by Oct. 30, 2026, or the shares face delisting.
• The panel can revisit the exception if events undermine the company’s ability to meet the conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TNL Mediagene published the original content used to generate this news brief on August 25, 2026, and is solely responsible for the information contained therein.